Distal phenylalanine modification for enhancing cellular delivery of fluorophores, proteins and quantum dots by cell penetrating peptides

Journal of Controlled Release

Volumn 195, Issue , 2014, Pages 55-62

  Sayers, E J ^a   Cleal, K ^a   Eissa, N G ^a,b   Watson, P ^a   Jones, A T ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Zagazig University   (Egypt)

Author keywords

Bovine serum albumin; Cell penetrating peptides; CPP; Phenylalanine; Protein delivery; Quantum dots

Indexed keywords

BODY FLUIDS; CELL MEMBRANES; CELLS; CYTOLOGY; FLUOROPHORES; HYDROPHOBICITY; MAMMALS; PEPTIDES; PROTEINS; SEMICONDUCTOR QUANTUM DOTS;

BOVINE SERUM ALBUMINS; CELL-PENETRATING PEPTIDE; CPP; PHENYLALANINE; PROTEIN DELIVERY;

AMINO ACIDS;

AMINO ACID; ARGININE; BOVINE SERUM ALBUMIN; CELL PENETRATING PEPTIDE; GLYCINE; OCTAARGININE; PENETRATIN; PHENYLALANINE; PROTEIN; QUANTUM DOT; UNCLASSIFIED DRUG; CARRIER PROTEIN; FLUORESCENT DYE; HYBRID PROTEIN; OLIGOPEPTIDE; TRANSPORTAN-10;

ADHERENT CELL; AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; CELL INTERACTION; CELL MEMBRANE; CHIMERA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HYDROPHOBICITY; IMAGE ANALYSIS; PROTEIN BINDING; PROTEIN MODIFICATION; CHEMISTRY; HELA CELL LINE; TUMOR CELL LINE;

CARRIER PROTEINS; CELL LINE, TUMOR; CELL-PENETRATING PEPTIDES; FLUORESCENT DYES; GLYCINE; HELA CELLS; HUMANS; OLIGOPEPTIDES; PHENYLALANINE; QUANTUM DOTS; RECOMBINANT FUSION PROTEINS; SERUM ALBUMIN, BOVINE;

EID: 84908696402     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.07.055     Document Type: Article

References (29)

1. M. Mae, and U. Langel Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery Curr. Opin. Pharmacol. 6 2006 509 514
2. D.S. Youngblood, S.A. Hatlevig, J.N. Hassinger, P.L. Iversen, and H.M. Moulton Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells Bioconjug. Chem. 18 2007 50 60
3. E. Carter, C.Y. Lau, D. Tosh, S.G. Ward, and R.J. Mrsny Cell penetrating peptides fail to induce an innate immune response in epithelial cells in vitro: implications for continued therapeutic use Eur. J. Pharm. Biopharm. 85 2013 12 19
4. el-S. Khafagy, M. Morishita, N. Ida, R. Nishio, K. Isowa, and K. Takayama Structural requirements of penetratin absorption enhancement efficiency for insulin delivery J. Control. Release 143 2010 302 310
5. K. Cleal, L. He, P.D. Watson, and A.T. Jones Endocytosis, intracellular traffic and fate of cell penetrating peptide based conjugates and nanoparticles Curr. Pharm. Des. 19 2013 2878 2894
6. F.C. Chien, C.W. Kuo, and P. Chen Localization imaging using blinking quantum dots Analyst 136 2011 1608 1613
7. F. Pinaud, S. Clarke, A. Sittner, and M. Dahan Probing cellular events, one quantum dot at a time Nat. Methods 7 2010 275 285
8. E. Petryayeva, W.R. Algar, and I.L. Medintz Quantum dots in bioanalysis: a review of applications across various platforms for fluorescence spectroscopy and imaging Appl. Spectrosc. 67 2013 215 252
9. B.R. Liu, Y.W. Huang, J.G. Winiarz, H.J. Chiang, and H.J. Lee Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism Biomaterials 32 2011 3520 3537
10. A.T. Jones, and E.J. Sayers Cell entry of cell penetrating peptides: tales of tails wagging dogs J. Control. Release 161 2012 582 591
11. C.L. Watkins, E.J. Sayers, C. Allender, D. Barrow, C. Fegan, P. Brennan, and A.T. Jones Co-operative membrane disruption between cell-penetrating peptide and cargo: implications for the therapeutic use of the Bcl-2 converter peptide D-NuBCP-9-r8 Mol. Ther. 19 2011 2124 2132
12. V.P. Reddy Chichili, V. Kumar, and J. Sivaraman Linkers in the structural biology of protein-protein interactions Protein Sci. 22 2013 153 167
13. C.L. Watkins, D. Schmaljohann, S. Futaki, and A.T. Jones Low concentration thresholds of plasma membranes for rapid energy-independent translocation of a cell-penetrating peptide Biochem. J. 420 2009 179 189
14. C.A. Schneider, W.S. Rasband, and K.W. Eliceiri NIH Image to ImageJ: 25 years of image analysis Nat. Methods 9 2012 671 675
15. C.L. Watkins, P. Brennan, C. Fegan, K. Takayama, I. Nakase, S. Futaki, and A.T. Jones Cellular uptake, distribution and cytotoxicity of the hydrophobic cell penetrating peptide sequence PFVYLI linked to the proapoptotic domain peptide PAD J. Control. Release 140 2009 237 244
16. M.M. Fretz, N.A. Penning, S. Al-Taei, S. Futaki, T. Takeuchi, I. Nakase, G. Storm, and A.T. Jones Temperature-, concentration- and cholesterol-dependent translocation of L- and D-octa-arginine across the plasma and nuclear membrane of CD34 + leukaemia cells Biochem. J. 403 2007 335 342
17. K. Takayama, H. Hirose, G. Tanaka, S. Pujals, S. Katayama, I. Nakase, and S. Futaki Effect of the attachment of a penetration accelerating sequence and the influence of hydrophobicity on octaarginine-mediated intracellular delivery Mol. Pharm. 9 2012 1222 1230
18. K. Takayama, I. Nakase, H. Michiue, T. Takeuchi, K. Tomizawa, H. Matsui, and S. Futaki Enhanced intracellular delivery using arginine-rich peptides by the addition of penetration accelerating sequences (Pas) J. Control. Release 138 2009 128 133
19. J.A. Killian, and G. von Heijne How proteins adapt to a membrane-water interface Trends Biochem. Sci. 25 2000 429 434
20. Z.G. Peng, K. Hidajat, and M.S. Uddin Selective and sequential adsorption of bovine serum albumin and lysozyme from a binary mixture on nanosized magnetic particles J. Colloid Interface Sci. 281 2005 11 17
21. S. Aubry, F. Burlina, E. Dupont, D. Delaroche, A. Joliot, S. Lavielle, G. Chassaing, and S. Sagan Cell-surface thiols affect cell entry of disulfide-conjugated peptides FASEB J. 23 2009 2956 2967
22. H. Yukawa, M. Watanabe, N. Kaji, Y. Okamoto, M. Tokeshi, Y. Miyamoto, H. Noguchi, Y. Baba, and S. Hayashi Monitoring transplanted adipose tissue-derived stem cells combined with heparin in the liver by fluorescence imaging using quantum dots Biomaterials 33 2012 2177 2186
23. B.R. Liu, J.S. Liou, Y.W. Huang, R.S. Aronstam, and H.J. Lee Intracellular delivery of nanoparticles and DNAs by IR9 cell-penetrating peptides PLoS One 8 2013 e64205
24. G.R. Dakwar, E. Zagato, J. Delanghe, S. Hobel, A. Aigner, H. Denys, K. Braeckmans, W. Ceelen, S.C. De Smedt, and K. Remaut Colloidal stability of nano-sized particles in the peritoneal fluid: towards optimizing drug delivery systems for intraperitoneal therapy Acta Biomater. 10 7 2014 2965 2975
25. R.C. Van Lehn, and A. Alexander-Katz Ligand-mediated short-range attraction drives aggregation of charged monolayer-protected gold nanoparticles Langmuir 29 2013 8788 8798
26. H.Y. Lei, and C.P. Chang Lectin of Concanavalin A as an anti-hepatoma therapeutic agent J. Biomed. Sci. 16 2009 10
27. C.P. Chang, M.C. Yang, H.S. Liu, Y.S. Lin, and H.Y. Lei Concanavalin A induces autophagy in hepatoma cells and has a therapeutic effect in a murine in situ hepatoma model Hepatology 45 2007 286 296
28. Z. Shi, J. Chen, C.Y. Li, N. An, Z.J. Wang, S.L. Yang, K.F. Huang, and J.K. Bao Antitumor effects of concanavalin A and Sophora flavescens lectin in vitro and in vivo Acta Pharmacol. Sin. 35 2014 248 256
29. B.C. Lagerholm, M. Wang, L.A. Ernst, D.H. Ly, H. Liu, M.P. Bruchez, and A.S. Waggoner Multicolor coding of cells with cationic peptide coated quantum dots Nano Lett. 4 2004 2019 2022